MiMedx Valuation

MDXG Stock  USD 7.70  0.09  1.18%   
At this time, the firm appears to be fairly valued. MiMedx Group secures a last-minute Real Value of $7.91 per share. The latest price of the firm is $7.7. Our model forecasts the value of MiMedx Group from analyzing the firm fundamentals such as return on equity of 0.62, and Profit Margin of 0.18 % as well as examining its technical indicators and probability of bankruptcy. In general, most investors recommend locking in undervalued stocks and disposing overvalued stocks since, at some point, asset prices and their ongoing real values will merge together.
Price Book
7.8362
Enterprise Value
1.1 B
Enterprise Value Ebitda
26.7654
Price Sales
3.4788
Forward PE
23.8095
Fairly Valued
Today
7.70
Please note that MiMedx's price fluctuation is somewhat reliable at this time. Calculation of the real value of MiMedx Group is based on 3 months time horizon. Increasing MiMedx's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for MiMedx Group is useful when determining the fair value of the MiMedx stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of MiMedx. Since MiMedx is currently traded on the exchange, buyers and sellers on that exchange determine the market value of MiMedx Stock. However, MiMedx's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  7.7 Real  7.91 Target  12.06 Hype  7.7 Naive  7.73
The real value of MiMedx Stock, also known as its intrinsic value, is the underlying worth of MiMedx Group Company, which is reflected in its stock price. It is based on MiMedx's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of MiMedx's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence MiMedx's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
7.91
Real Value
10.47
Upside
Estimating the potential upside or downside of MiMedx Group helps investors to forecast how MiMedx stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of MiMedx more accurately as focusing exclusively on MiMedx's fundamentals will not take into account other important factors:
Earnings
Estimates (0)
LowProjectedHigh
0.030.040.06
Details
Hype
Prediction
LowEstimatedHigh
5.147.7010.26
Details
Naive
Forecast
LowNext ValueHigh
5.167.7310.29
Details
4 Analysts
Consensus
LowTarget PriceHigh
10.9712.0613.39
Details

MiMedx Investments

(3.55 Million)

MiMedx Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining MiMedx's current stock value. Our valuation model uses many indicators to compare MiMedx value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across MiMedx competition to find correlations between indicators driving MiMedx's intrinsic value. More Info.
MiMedx Group is regarded second in price to book category among related companies. It is regarded third in net asset category among related companies making up about  30,505,475  of Net Asset per Price To Book. . Comparative valuation analysis is a catch-all model that can be used if you cannot value MiMedx by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for MiMedx's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the MiMedx's earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates MiMedx's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in MiMedx and how it compares across the competition.

About MiMedx Valuation

The stock valuation mechanism determines the current worth of MiMedx Group on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of MiMedx Group. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of MiMedx Group based exclusively on its fundamental and basic technical indicators. By analyzing MiMedx's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of MiMedx's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of MiMedx. We calculate exposure to MiMedx's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to MiMedx's related companies.
Last ReportedProjected for 2024
Gross Profit266.8 M188.8 M
Pretax Profit Margin 0.1  0.10 
Operating Profit Margin 0.12  0.12 
Net Profit Margin 0.21  0.22 
Gross Profit Margin 0.83  0.55 

8 Steps to conduct MiMedx's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates MiMedx's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct MiMedx's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain MiMedx's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine MiMedx's revenue streams: Identify MiMedx's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research MiMedx's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish MiMedx's growth potential: Evaluate MiMedx's management, business model, and growth potential.
  • Determine MiMedx's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate MiMedx's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

MiMedx Growth Indicators

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as MiMedx does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding146 M
Quarterly Earnings Growth Y O Y4
Forward Price Earnings23.8095

MiMedx Current Valuation Indicators

Valuation refers to the process of determining the present value of MiMedx Group and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value MiMedx we look at many different elements of the entity such as MiMedx's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. MiMedx's valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final MiMedx's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as MiMedx, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use MiMedx's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes MiMedx's worth.
When determining whether MiMedx Group is a strong investment it is important to analyze MiMedx's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact MiMedx's future performance. For an informed investment choice regarding MiMedx Stock, refer to the following important reports:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MiMedx Group. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest.
You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Complementary Tools for MiMedx Stock analysis

When running MiMedx's price analysis, check to measure MiMedx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MiMedx is operating at the current time. Most of MiMedx's value examination focuses on studying past and present price action to predict the probability of MiMedx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MiMedx's price. Additionally, you may evaluate how the addition of MiMedx to your portfolios can decrease your overall portfolio volatility.
Money Managers
Screen money managers from public funds and ETFs managed around the world
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Is MiMedx's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MiMedx. If investors know MiMedx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MiMedx listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
4
Earnings Share
0.43
Revenue Per Share
2.76
Quarterly Revenue Growth
0.167
Return On Assets
0.113
The market value of MiMedx Group is measured differently than its book value, which is the value of MiMedx that is recorded on the company's balance sheet. Investors also form their own opinion of MiMedx's value that differs from its market value or its book value, called intrinsic value, which is MiMedx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MiMedx's market value can be influenced by many factors that don't directly affect MiMedx's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MiMedx's value and its price as these two are different measures arrived at by different means. Investors typically determine if MiMedx is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MiMedx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.